Marieke Rueth

Mrs. Marieke Rueth

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2014 in Toxins
Verified
Journal Article
Open access
PDF file
EDEric Devine
Eric Devine
DKDetlef Krieter
Detlef Krieter
MRMarieke Rueth
Marieke Rueth
JJJoachim Jankowski
Joachim Jankowski
HLHorst-Dieter Lemke
Horst-Dieter Lemke
Protein binding prevents uremic toxins from removal by conventional extracorporeal therapies leading to accumulation in maintenance dialysis patients. Weakening of the protein binding may enhance the dialytic elimination of these toxins. In ultrafiltration and equilibrium dialysis experiments, different measures to modify the plasma binding affinity and capacity were tested: (i), increasing the sodium chloride (NaCl) concentration to achieve a higher ionic strength; (ii), increasing the temperature; and (iii), dilution. The effects on the dissociation constant KD and the protein bound fraction of the prototypical uremic toxin indoxyl sulfate (IS) in plasma of healthy and uremic individuals were studied. Binding of IS corresponded to one site binding in normal plasma. KD increased linearly with the NaCl concentration between 0.15 (KD = 13.2 ± 3.7 µM) and 0.75 M (KD = 56.2 ± 2.0 µM). Plasma dilution further reduced the protein bound toxin fraction by lowering the protein binding capacity of the plasma. Higher temperatures also decreased the protein bound fraction of IS in human plasma. Increasing the NaCl concentration was effective to weaken the binding of IS also in uremic plasma: the protein bound fraction decreased from 89% ± 3% to 81% ± 3% at 0.15 and 0.75 M NaCl, respectively. Dilution and increasing the ionic strength and temperature enhance the free fraction of IS allowing better removal of the substance during dialysis. Applied during clinical dialysis, this may have beneficial effects on the long-term outcome of maintenance dialysis patients.

1 November 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NCNatalia Vladimirovna Chevtchik
Natalia Vladimirovna Chevtchik
MFMichele Fedecostante
Michele Fedecostante
JJJitske Jansen
Jitske Jansen
MMMilos Mihajlovic
Milos Mihajlovic
MWMartijn Wilmer
Martijn Wilmer
DSDimitrios Stamatialis
Dimitrios Stamatialis

1 October 2018 in Optics & Laser Technology
Verified
Journal Article
Closed access
ATAnika Trautmann
Anika Trautmann
MRMarieke Rueth
Marieke Rueth
HLHorst-Dieter Lemke
Horst-Dieter Lemke
TWThomas Walther
Thomas Walther
Ralf HellmannRalf Hellmann
Ralf Hellmann

22 June 2016 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
DKDetlef Krieter
Detlef Krieter
EDEric Devine
Eric Devine
TKThomas Körner
Thomas Körner
MRMarieke Rueth
Marieke Rueth
CWChristoph Wanner
Christoph Wanner
HLHorst‐Dieter Lemke
Horst‐Dieter Lemke

16 January 2019 in Toxins
Verified
Journal Article
Open access
PDF file
DKDetlef Krieter
Detlef Krieter
SKSimon Kerwagen
Simon Kerwagen
MRMarieke Rueth
Marieke Rueth
HLHorst-Dieter Lemke
Horst-Dieter Lemke
CWChristoph Wanner
Christoph Wanner
The protein-bound uremic toxins para-cresyl sulfate (pCS) and indoxyl sulfate (IS) are associated with cardiovascular disease in chronic renal failure, but the effect of different dialysis procedures on their plasma levels over time is poorly studied. The present prospective, randomized, cross-over trial tested dialysis efficacy and monitored pre-treatment pCS and IS concentrations in 15 patients on low-flux and high-flux hemodialysis and high-convective volume postdilution hemodiafiltration over six weeks each. Although hemodiafiltration achieved by far the highest toxin removal, only the mean total IS level was decreased at week three (16.6 ± 12.1 mg/L) compared to baseline (18.9 ± 13.0 mg/L, p = 0.027) and to low-flux dialysis (20.0 ± 12.7 mg/L, p = 0.021). At week six, the total IS concentration in hemodiafiltration reached the initial values again. Concentrations of free IS and free and total pCS remained unaltered. Highest beta2-microglobulin elimination in hemodiafiltration (p < 0.001) led to a persistent decrease of the plasma levels at week three and six (each p < 0.001). In contrast, absent removal in low-flux dialysis resulted in rising beta2-microglobulin concentrations (p < 0.001). In conclusion, this trial demonstrated that even large differences in instantaneous protein-bound toxin removal by current extracorporeal dialysis techniques may have only limited impact on IS and pCS plasma levels in the longer term.

7 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DJDoreen Janke
Doreen Janke
JJJoachim Jankowski
Joachim Jankowski
MRMarieke Rueth
Marieke Rueth
IBIvo Buschmann
Ivo Buschmann
HLHorst-Dieter Lemke
Horst-Dieter Lemke
VJVera Jankowski
Vera Jankowski
Metabolic stimuli, pressure, and fluid shear stress (FSS) are major mediators of vascular plasticity. The exposure of the vessel wall to increased laminar FSS is the main trigger of arteriogenesis, the remodelling of pre-existent arterio-arteriolar anastomoses to functional conductance arteries. In this study, we have used an in vitro bioreactor to investigate cell-specific interactions, molecular mechanisms as well as time-dependent effects under laminar FSS conditions. This bioreactor termed “artificial artery” can be used for screening potential arterio-protective substances, pro-arteriogenic factors, and for investigating biomarkers of cardiovascular diseases such as cardiac diseases. The bioreactor is built up out of 14 hollow fiber membranes colonized with endothelial cells (HUVECs) on the inside and smooth muscle cells (HUASMCs) on the outside. By means of Hoechst 33342 staining as well as immunocytochemistry of ß-catenin and α-smooth-muscle-actin, a microporous polypropylene membrane was characterized as being the appropriate polymer for co-colonization. Defined arterial flow conditions (0.1 N/m2 and 3 N/m2), metabolic exchange, and cross-talk of HUVECs and HUASMCs through hollow fibers mimic physiological in vivo conditions of the vasculature. Analysing mono- and co-culture secretomes by MALDI-TOF-TOF mass spectrometry, we could show that HUVECs secreted Up4A upon 3 N/m2. A constant cellular secretion of randomly chosen peptides verified viability of the “artificial artery” for a cultivation period up to five days. qRT-PCR analyses revealed an up-regulation of KLF2 and TIMP1 as mechano-regulated genes and demonstrated arterio-protective, homeostatic FSS conditions by a down-regulation of EDN1. Expression analyses of VWF and EDN1 furthermore confirmed that RNA of both cell types could separately be isolated without cross-contamination. CCND1 mRNA expression in HUVECs did not change upon FSS indicating a quiescent endothelial phenotype. Taken together, the “artificial artery” provides a solid in vitro model to test pharmacological active compounds for their impact on arterio-damaging or arterio-protective properties on vascular response.